- Nuvaxovid is a protein-based Covid-19 vaccine.
- Sanofi is expanding vaccine choice for Canadians.
Sanofi announced the availability of its Nuvaxovid Covid-19 vaccine for Canadians for the 2026-2027 respiratory season, expanding vaccine choice.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.